发明名称 Pulmonary delivery for levodopa
摘要 In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
申请公布号 US8586093(B2) 申请公布日期 2013.11.19
申请号 US201313773054 申请日期 2013.02.21
申请人 CIVITAS THERAPEUTICS, INC.;CIVITAS THERAPEUTICS 发明人 JACKSON BLAIR;BENNETT DAVID J.;BARTUS RAYMOND T.;EMERICH DWAINE F.
分类号 A61K9/14;A01N37/44;A61K9/00;A61K9/16;A61K9/68;A61K31/135;A61K31/137;A61K31/198;A61K31/24;A61K31/70;A61L9/04 主分类号 A61K9/14
代理机构 代理人
主权项
地址